Oxaliplatin-Induced Lung Injury with Allergic Reaction

被引：4

作者：

Homma, Tetsuya ^{[1
]}

Kurokawa, Masatsugu ^{[1
]}

Yamamoto, Yoshitaka ^{[1
]}

Matsukura, Satoshi ^{[1
]}

Ieki, Koushi ^{[1
]}

Suzuki, Shintaro ^{[1
]}

Odaka, Miho ^{[1
]}

Watanabe, Shin ^{[1
]}

Yamaguchi, Munehiro ^{[1
]}

Adachi, Mitsuru ^{[1
]}

机构：

[1] Showa Univ, Sch Med, Div Allergol & Resp Med, Div Internal Med,Shinagawa Ku, Tokyo 142, Japan

来源：

CHINESE JOURNAL OF CANCER RESEARCH | 2011年 / 23卷 / 03期

关键词：

Oxaliplatin; mFOLFOX6; Drug-induced pneumonia; Drug lymphocyte stimulating test; Immunoglobulin E; OBLITERANS ORGANIZING PNEUMONIA; HYPERSENSITIVITY REACTIONS; COLORECTAL-CANCER; CHEMOTHERAPY; 5-FLUOROURACIL; LEUCOVORIN; DISEASE; FLUOROURACIL; DIAGNOSIS;

D O I：

10.1007/s11670-011-0232-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen. On the 12th cycle, we observed erythema and dyspnea. Radiographs showed ground grass opacities. Blood tests showed elevated levels of eosinophils and immunoglobulin E. We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone. The treatment was successful and he was discharged. The drug lymphocyte stimulating test against oxaliplatin was positive, indicating a type I and IV allergic reaction due to oxaliplatin. Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed.

引用

页码：232 / 235

页数：4

共 28 条

[11] Makrilia Nektaria, 2010, Metal-Based Drugs, P207084, DOI 10.1155/2010/207084
[12] Hypersensitivity reactions to oxaliplatin: Cross-reactivity to carboplatin and the introduction of a desensitization schedule
Meyer, L
Zuberbier, T
Worm, M
Oettle, H
Riess, H
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1146 - 1147
[13] Diagnosis and management of drug-associated interstitial lung disease
Müller, NL
White, DA
Jiang, H
Gemma, A
[J]. BRITISH JOURNAL OF CANCER, 2004, 91 (Suppl 2) : S24 - S30
[14] Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer
Mundt, Pamela
Mochmann, Hans-Christian
Ebhardt, Harald
Zeitz, Martin
Duchmann, Rainer
Pauschinger, Matthias
[J]. ONCOLOGY, 2007, 73 (3-4) : 270 - 272
[15] Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX)
Muneoka, Katsuki
Shirai, Yoshio
Sasaki, Masataka
Wakai, Toshifumi
Sakata, Jun
Hatakeyama, Katsuyoshi
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 457 - 459
[16] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
NARANJO, CA
BUSTO, U
SELLERS, EM
SANDOR, P
RUIZ, I
ROBERTS, EA
JANECEK, E
DOMECQ, C
GREENBLATT, DJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
[17] Ohori Hisatsugu, 2009, Gan To Kagaku Ryoho, V36, P295
[18] Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin
Pagani, M.
Bonadonna, P.
Senna, G. E.
Antico, A.
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2008, 145 (01) : 54 - 57
[19] Is acute dyspnea related to oxaliplatin administration?
Pasetto, L. M.
Monfardini, S.
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (36) : 5907 - 5908
[20] Interstitial lung disease associated with oxaliplatin: description of two cases
Pena Alvarez, Carolina
Suh Oh, Hae Jin
de Miera Rodriguez, Andrea Saenz
Garcia Arroyo, Francisco Ramon
Covela Rua, Marta
Salgado Boquete, Laura
Lopez Clemente, Pedro Miguel
Constenla Figueiras, Manuel
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (05) : 332 - 333

← 1 2 3 →